Rome, Italy

Bianco Armandodariano

This inventor holds 1 USPTO granted patent. Top assignee: Istituto Chimico Internazionale Dr. Giuseppe Rende S.r.l.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bianco Armandodariano. Retrieved from https://idiyas.com/inventor/bianco-armandodariano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bianco Armandodariano: Innovator in Pharmaceutical Chemistry

Introduction

Bianco Armandodariano is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds related to acetazolamide. His work focuses on creating innovative solutions for medical treatments.

Latest Patents

Bianco Armandodariano holds a patent for "Acetazolamide-related compounds, process for their preparation." This patent includes compounds related to acetazolamide and its N-methyl derivatives, which are designed to inhibit carbonic anhydrase. The compounds he developed are well absorbed topically, making them suitable for treating glaucoma.

Career Highlights

Armandodariano is associated with Istituto Chimico Internazionale Dr. Giuseppe Rende S.r.l., where he applies his expertise in pharmaceutical research. His work has led to advancements in drug formulations that enhance therapeutic efficacy.

Collaborations

He collaborates with esteemed colleagues such as Lo B Giuseppe and Antonaroli Simonetta, contributing to a dynamic research environment that fosters innovation.

Conclusion

Bianco Armandodariano's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new treatments that improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…